Literature DB >> 9486662

Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts.

Y Zou1, I Komuro, T Yamazaki, S Kudoh, R Aikawa, W Zhu, I Shiojima, Y Hiroi, K Tobe, T Kadowaki, Y Yazaki.   

Abstract

Angiotensin II (Ang II) induces hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. To determine the molecular mechanism by which Ang II displayed different effects on cardiac myocytes and fibroblasts, we examined signal transduction pathways leading to activation of extracellular signal-regulated kinases (ERKs). Ang II-induced ERK activation was abolished by pretreatment with pertussis toxin and by overexpression of the Gbetagamma subunit-binding domain of the beta-adrenergic receptor kinase 1 in cardiac fibroblasts but not in cardiac myocytes. Inhibition of protein kinase C strongly inhibited activation of ERKs by Ang II in cardiac myocytes, whereas inhibitors of tyrosine kinases but not of protein kinase C abolished Ang II-induced ERK activation in cardiac fibroblasts. Overexpression of C-terminal Src kinase (Csk), which inactivates Src family tyrosine kinases, suppressed the activation of transfected ERK in cardiac fibroblasts. Ang II rapidly induced phosphorylation of Shc and association of Shc with Grb2. Cotransfection of the dominant-negative mutant of Ras or Raf-1 kinase abolished Ang II-induced ERK activation in cardiac fibroblasts. Overexpression of Csk or the dominant-negative mutant of Ras had no effects on Ang II-induced ERK activation in cardiac myocytes. These findings suggest that Ang II-evoked signal transduction pathways differ among cell types. In cardiac fibroblasts, Ang II activates ERKs through a pathway including the Gbetagamma subunit of Gi protein, tyrosine kinases including Src family tyrosine kinases, Shc, Grb2, Ras, and Raf-1 kinase, whereas Gq and protein kinase C are important in cardiac myocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486662     DOI: 10.1161/01.res.82.3.337

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  21 in total

1.  Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.

Authors:  N E Rhaleb; H Peng; P Harding; M Tayeh; M C LaPointe; O A Carretero
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

2.  Growth hormone signalling and apoptosis in neonatal rat cardiomyocytes.

Authors:  Y Gu; Y Zou; R Aikawa; D Hayashi; S Kudoh; T Yamauchi; H Uozumi; W Zhu; T Kadowaki; Y Yazaki; I Komuro
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

Review 3.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

4.  Angiotensin II-induced MMP-2 activity and MMP-14 and basigin protein expression are mediated via the angiotensin II receptor type 1-mitogen-activated protein kinase 1 pathway in retinal pigment epithelium: implications for age-related macular degeneration.

Authors:  Marianne Pons; Scott W Cousins; Oscar Alcazar; Gary E Striker; Maria E Marin-Castaño
Journal:  Am J Pathol       Date:  2011-06       Impact factor: 4.307

5.  Mechanoactivation of the angiotensin II type 1 receptor induces β-arrestin-biased signaling through Gαi coupling.

Authors:  Jialu Wang; Kenji Hanada; Clarice Gareri; Howard A Rockman
Journal:  J Cell Biochem       Date:  2018-01-04       Impact factor: 4.429

6.  Effects of ACE inhibition and angiotensin II type 1 receptor blockade on cardiac function and G proteins in rats with chronic heart failure.

Authors:  H Yoshida; M Takahashi; K Tanonaka; T Maki; Y Nasa; S Takeo
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

7.  Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling.

Authors:  Yan G Ni; Kambeez Berenji; Na Wang; Misook Oh; Nita Sachan; Asim Dey; Jun Cheng; Guangrong Lu; David J Morris; Diego H Castrillon; Robert D Gerard; Beverly A Rothermel; Joseph A Hill
Journal:  Circulation       Date:  2006-09-04       Impact factor: 29.690

8.  Gαi2 signaling: friend or foe in cardiac injury and heart failure?

Authors:  Kuljeet Kaur; Sergio Parra; Rong Chen; Raelene A Charbeneau; Susan M Wade; Patrick Y Jay; Richard R Neubig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-03-14       Impact factor: 3.000

9.  A3 adenosine and CB1 receptors activate a PKC-sensitive Cl- current in human nonpigmented ciliary epithelial cells via a G beta gamma-coupled MAPK signaling pathway.

Authors:  Chanjuan Shi; Anna Szczesniak; Lucy Mao; Christine Jollimore; Miguel Coca-Prados; Orlando Hung; Melanie E M Kelly
Journal:  Br J Pharmacol       Date:  2003-06       Impact factor: 8.739

10.  Epigallocatechin-3 gallate prevents cardiac hypertrophy induced by pressure overload in rats.

Authors:  Jia Hao; Chan-Hyung Kim; Tae-Sun Ha; Hee-Yul Ahn
Journal:  J Vet Sci       Date:  2007-06       Impact factor: 1.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.